Bowhead Specialty (BOW) Financials

$37.29 +0.13 (+0.35%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$37.29 0.00 (0.00%)

As of 05/30/2025 06:06 PM Eastern

Annual Income Statements for Bowhead Specialty

This table shows Bowhead Specialty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	38	25	11
Consolidated Net Income / (Loss)	38	25	11
Net Income / (Loss) Continuing Operations	38	25	11
Total Pre-Tax Income	51	32	15
Total Operating Income	88	54	30
Total Gross Profit	178	117	76
Total Revenue	426	283	188
Operating Revenue	426	283	188
Total Cost of Revenue	248	166	112
Operating Cost of Revenue	248	166	112
Total Operating Expenses	89	63	46
Other Operating Expenses / (Income)	89	63	46
Total Other Income / (Expense), net	-38	-22	-15
Interest Expense	0.73	0.00	0.00
Other Income / (Expense), net	-37	-22	-15
Income Tax Expense	12	7.07	3.41
Basic Earnings per Share	$1.31	$1.04	$0.47
Weighted Average Basic Shares Outstanding	29.26M	24M	24M
Diluted Earnings per Share	$1.29	$1.04	$0.47
Weighted Average Diluted Shares Outstanding	29.68M	24M	24M
Weighted Average Basic & Diluted Shares Outstanding	32.66M	-	-

This table shows Bowhead Specialty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q3 2023	Q2 2023
Period end date	3/31/2025	9/30/2024	6/30/2024	9/30/2023	6/30/2023
Net Income / (Loss) Attributable to Common Shareholders	11	12	5.53	8.71	6.56
Consolidated Net Income / (Loss)	11	12	5.53	8.71	6.56
Net Income / (Loss) Continuing Operations	11	12	5.53	8.71	6.56
Total Pre-Tax Income	14	16	7.41	11	8.46
Total Operating Income	25	27	17	17	13
Total Gross Profit	49	49	40	33	28
Total Revenue	123	117	99	76	65
Operating Revenue	123	117	99	76	65
Total Cost of Revenue	73	68	59	43	37
Operating Cost of Revenue	73	68	59	43	37
Total Operating Expenses	24	22	23	16	15
Other Operating Expenses / (Income)	24	22	23	16	15
Total Other Income / (Expense), net	-11	-11	-9.62	-5.66	-4.97
Interest Expense	0.25	0.25	0.22	0.00	0.00
Other Income / (Expense), net	-11	-10	-9.39	-5.66	-4.97
Income Tax Expense	3.05	3.73	1.88	2.56	1.91
Basic Earnings per Share	$0.35	$0.37	$0.20	$0.36	$0.27
Weighted Average Basic Shares Outstanding	32.66M	32.66M	27.65M	24M	24M
Diluted Earnings per Share	$0.34	$0.36	$0.20	$0.36	$0.27
Weighted Average Diluted Shares Outstanding	33.71M	33.26M	27.77M	24M	24M
Weighted Average Basic & Diluted Shares Outstanding	32.66M	32.66M	32.66M	-	-

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	102	39	-6.81
Net Cash From Operating Activities	294	236	182
Net Cash From Continuing Operating Activities	294	236	182
Net Income / (Loss) Continuing Operations	38	25	11
Consolidated Net Income / (Loss)	38	25	11
Depreciation Expense	3.87	2.27	0.73
Amortization Expense	-3.51	-2.85	-0.07
Non-Cash Adjustments To Reconcile Net Income	267	224	175
Changes in Operating Assets and Liabilities, net	-11	-13	-5.31
Net Cash From Investing Activities	-326	-275	-187
Net Cash From Continuing Investing Activities	-326	-275	-187
Purchase of Property, Plant & Equipment	-3.11	-3.82	-3.97
Purchase of Investments	-613	-367	-198
Sale and/or Maturity of Investments	290	96	15
Net Cash From Financing Activities	134	78	-1.00
Net Cash From Continuing Financing Activities	134	78	-1.00
Payment of Dividends	0.00	0.00	-25
Issuance of Common Equity	131	0.00	0.00
Other Financing Activities, net	2.90	78	24
Cash Income Taxes Paid	16	14	5.29

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	12/31/2023	9/30/2023
Net Change in Cash & Equivalents	-99	60	-37	-15	52
Net Cash From Operating Activities	48	61	119	61	88
Net Cash From Continuing Operating Activities	48	62	119	62	88
Net Income / (Loss) Continuing Operations	11	14	12	4.78	8.71
Consolidated Net Income / (Loss)	11	14	12	4.78	8.71
Depreciation Expense	0.40	1.10	1.05	0.81	0.78
Amortization Expense	-0.37	-0.58	-0.86	-1.01	-0.76
Non-Cash Adjustments To Reconcile Net Income	49	292	23	219	-79
Changes in Operating Assets and Liabilities, net	-13	-244	84	-161	158
Net Cash From Investing Activities	-146	-1.14	-157	-101	-59
Net Cash From Continuing Investing Activities	-146	-1.14	-157	-101	-59
Purchase of Property, Plant & Equipment	-1.23	-0.51	-1.01	-0.92	-1.09
Purchase of Investments	-251	-145	-239	-128	-62
Sale and/or Maturity of Investments	105	144	83	28	3.86
Net Cash From Financing Activities	0.00	0.06	-	25	22
Net Cash From Continuing Financing Activities	0.00	0.06	-	25	22
Other Financing Activities, net	0.00	0.06	-	25	22

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023
Period end date	12/31/2024	12/31/2023
Total Assets	1,654	1,028
Total Current Assets	559	313
Cash & Equivalents	97	118
Restricted Cash	125	1.70
Short-Term Investments	18	13
Current Deferred & Refundable Income Taxes	0.59	1.11
Other Current Assets	319	178
Plant, Property, & Equipment, net	6.85	7.60
Total Noncurrent Assets	1,098	717
Noncurrent Deferred & Refundable Income Taxes	20	14
Other Noncurrent Operating Assets	1,078	702
Total Liabilities & Shareholders' Equity	1,654	1,028
Total Liabilities	1,284	836
Total Current Liabilities	1,275	831
Accrued Expenses	18	15
Current Deferred & Payable Income Tax Liabilities	1.57	0.04
Other Current Liabilities	1,256	816
Total Noncurrent Liabilities	8.65	4.51
Other Noncurrent Operating Liabilities	8.65	4.51
Commitments & Contingencies	0.00	0.00
Redeemable Noncontrolling Interest	0.27	0.00
Total Equity & Noncontrolling Interests	370	192
Total Preferred & Common Equity	370	192
Total Common Equity	370	192
Common Stock	318	179
Retained Earnings	63	25
Accumulated Other Comprehensive Income / (Loss)	-11	-11

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024
Period end date	3/31/2025	9/30/2024	6/30/2024
Total Assets	1,753	1,548	1,395
Total Current Assets	500	451	481
Cash & Equivalents	88	133	180
Restricted Cash	35	29	18
Short-Term Investments	18	17	19
Current Deferred & Refundable Income Taxes	0.61	0.33	1.32
Other Current Assets	358	272	262
Plant, Property, & Equipment, net	7.68	7.44	7.48
Total Noncurrent Assets	1,256	1,099	919
Noncurrent Deferred & Refundable Income Taxes	19	16	17
Other Noncurrent Operating Assets	1,236	1,083	902
Total Liabilities & Shareholders' Equity	1,753	1,548	1,395
Total Liabilities	1,362	1,183	1,055
Total Current Liabilities	1,352	1,176	1,037
Accrued Expenses	5.78	15	11
Current Deferred & Payable Income Tax Liabilities	5.60	0.03	0.03
Other Current Liabilities	1,341	1,161	1,025
Total Noncurrent Liabilities	9.41	7.29	18
Other Noncurrent Operating Liabilities	9.41	7.29	18
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.41	0.16	0.05
Total Equity & Noncontrolling Interests	391	365	340
Total Preferred & Common Equity	391	365	340
Total Common Equity	391	365	340
Common Stock	320	317	315
Retained Earnings	74	49	37
Accumulated Other Comprehensive Income / (Loss)	-3.74	-1.29	-12

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	50.20%	51.06%	0.00%
EBITDA Growth	63.69%	105.87%	0.00%
EBIT Growth	59.61%	119.05%	0.00%
NOPAT Growth	59.94%	82.58%	0.00%
Net Income Growth	52.69%	122.52%	0.00%
EPS Growth	24.04%	121.28%	0.00%
Operating Cash Flow Growth	24.58%	30.05%	0.00%
Free Cash Flow Firm Growth	75.66%	0.00%	0.00%
Invested Capital Growth	108.23%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-
Gross Margin	41.71%	41.33%	40.43%
EBITDA Margin	12.13%	11.13%	8.17%
Operating Margin	20.78%	18.93%	15.91%
EBIT Margin	12.04%	11.33%	7.81%
Profit (Net Income) Margin	8.98%	8.84%	6.00%
Tax Burden Percent	75.68%	77.99%	76.78%
Interest Burden Percent	98.59%	100.00%	100.00%
Effective Tax Rate	24.32%	22.01%	23.22%
Return on Invested Capital (ROIC)	64.20%	123.73%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	80.41%	150.74%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-50.60%	-97.65%	0.00%
Return on Equity (ROE)	13.60%	26.08%	0.00%
Cash Return on Invested Capital (CROIC)	-6.02%	-76.27%	0.00%
Operating Return on Assets (OROA)	3.82%	3.12%	0.00%
Return on Assets (ROA)	2.85%	2.44%	0.00%
Return on Common Equity (ROCE)	13.59%	26.08%	0.00%
Return on Equity Simple (ROE_SIMPLE)	10.33%	13.04%	0.00%
Net Operating Profit after Tax (NOPAT)	67	42	23
NOPAT Margin	15.72%	14.77%	12.22%
Net Nonoperating Expense Percent (NNEP)	-16.21%	-27.01%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	18.08%	21.79%	-
Cost of Revenue to Revenue	58.29%	58.67%	59.57%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.94%	22.39%	24.51%
Earnings before Interest and Taxes (EBIT)	51	32	15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	52	32	15
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.13	0.67	0.00
Price to Tangible Book Value (P/TBV)	3.13	0.67	0.00
Price to Revenue (P/Rev)	2.73	0.45	0.68
Price to Earnings (P/E)	30.33	5.11	11.37
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	3.30%	19.57%	8.79%
Enterprise Value to Invested Capital (EV/IC)	6.54	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.16	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	17.84	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	17.96	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	13.76	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.13	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.63	-0.65	0.00
Leverage Ratio	4.77	5.35	0.00
Compound Leverage Factor	4.70	5.35	0.00
Debt to Total Capital	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.07%	0.00%	0.00%
Common Equity to Total Capital	99.93%	100.00%	0.00%
Debt to EBITDA	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	0.44	-0.10	0.00
Noncontrolling Interest Sharing Ratio	0.05%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	0.44	0.38	0.00
Quick Ratio	0.09	0.16	0.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-6.28	-26	0.00
Operating Cash Flow to CapEx	9,456.52%	6,185.52%	4,573.11%
Free Cash Flow to Firm to Interest Expense	-8.66	0.00	0.00
Operating Cash Flow to Interest Expense	405.91	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	401.62	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.32	0.28	0.00
Accounts Receivable Turnover	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	58.93	37.28	0.00
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	141	68	0.00
Invested Capital Turnover	4.08	8.38	0.00
Increase / (Decrease) in Invested Capital	73	68	0.00
Enterprise Value (EV)	921	-5.25	0.00
Market Capitalization	1,160	128	128
Book Value per Share	$11.33	$8.00	$0.00
Tangible Book Value per Share	$11.33	$8.00	$0.00
Total Capital	370	192	0.00
Total Debt	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-240	-133	0.00
Capital Expenditures (CapEx)	3.11	3.82	3.97
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-956	-652	0.00
Debt-free Net Working Capital (DFNWC)	-716	-519	0.00
Net Working Capital (NWC)	-716	-519	0.00
Net Nonoperating Expense (NNE)	29	17	12
Net Nonoperating Obligations (NNO)	-230	-124	0.00
Total Depreciation and Amortization (D&A)	0.36	-0.58	0.66
Debt-free, Cash-free Net Working Capital to Revenue	-224.55%	-230.05%	0.00%
Debt-free Net Working Capital to Revenue	-168.27%	-183.03%	0.00%
Net Working Capital to Revenue	-168.27%	-183.03%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.31	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	29.26M	0.00	0.00
Adjusted Diluted Earnings per Share	$1.29	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	29.68M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.66M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	67	42	23
Normalized NOPAT Margin	15.72%	14.77%	12.22%
Pre Tax Income Margin	11.87%	11.33%	7.81%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	70.70	0.00	0.00
NOPAT to Interest Expense	92.32	0.00	0.00
EBIT Less CapEx to Interest Expense	66.41	0.00	0.00
NOPAT Less CapEx to Interest Expense	88.03	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	222.10%
Augmented Payout Ratio	0.00%	0.00%	222.10%

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric	Q1 2025	Q3 2024	Q2 2024	Q3 2023	Q2 2023
Period end date	3/31/2025	9/30/2024	6/30/2024	9/30/2023	6/30/2023
Growth Metrics	-	-	-	-	-
Revenue Growth	35.34%	53.45%	51.10%	0.00%	0.00%
EBITDA Growth	67.94%	44.10%	-9.76%	0.00%	0.00%
EBIT Growth	62.51%	42.68%	-9.76%	0.00%	0.00%
NOPAT Growth	63.31%	55.14%	22.18%	0.00%	0.00%
Net Income Growth	62.94%	38.86%	-15.59%	0.00%	0.00%
EPS Growth	17.24%	0.00%	-25.93%	0.00%	0.00%
Operating Cash Flow Growth	13.87%	35.32%	0.00%	0.00%	0.00%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	18.06%	0.00%	16.26%	0.00%
EBITDA Q/Q Growth	0.00%	112.97%	0.00%	33.36%	0.00%
EBIT Q/Q Growth	0.00%	110.53%	0.00%	33.14%	0.00%
NOPAT Q/Q Growth	0.00%	59.64%	0.00%	25.73%	0.00%
Net Income Q/Q Growth	0.00%	118.54%	0.00%	32.85%	0.00%
EPS Q/Q Growth	0.00%	80.00%	0.00%	33.33%	0.00%
Operating Cash Flow Q/Q Growth	-22.30%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	-44.43%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	45.87%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	40.17%	41.91%	40.32%	43.76%	42.85%
EBITDA Margin	12.02%	13.92%	7.72%	14.83%	12.93%
Operating Margin	20.66%	22.74%	17.21%	22.24%	20.52%
EBIT Margin	11.99%	13.76%	7.72%	14.80%	12.93%
Profit (Net Income) Margin	9.31%	10.36%	5.59%	11.44%	10.01%
Tax Burden Percent	78.96%	76.43%	74.67%	77.31%	77.48%
Interest Burden Percent	98.32%	98.43%	97.07%	100.00%	100.00%
Effective Tax Rate	21.04%	23.57%	25.33%	22.69%	22.52%
Return on Invested Capital (ROIC)	57.38%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	70.48%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-23.62%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	33.76%	0.00%	0.00%	0.00%	0.00%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	3.13%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	2.43%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	33.73%	0.00%	0.00%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	10.91%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	20	20	13	13	10
NOPAT Margin	16.31%	17.38%	12.85%	17.19%	15.90%
Net Nonoperating Expense Percent (NNEP)	-13.10%	-9.72%	-6.99%	0.00%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	5.12%	-	-	-	-
Cost of Revenue to Revenue	59.84%	58.09%	59.68%	56.24%	57.15%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.51%	19.17%	23.11%	21.52%	22.33%
Earnings before Interest and Taxes (EBIT)	15	16	7.63	11	8.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	15	16	7.63	11	8.46
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	3.40	2.51	0.56	0.00	0.00
Price to Tangible Book Value (P/TBV)	3.40	2.51	0.56	0.00	0.00
Price to Revenue (P/Rev)	2.90	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	31.13	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.21%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.56	3.76	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.59	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	20.61	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	20.85	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.89	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.96	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.34	-0.46	-0.60	0.00	0.00
Leverage Ratio	4.48	4.24	4.10	0.00	0.00
Compound Leverage Factor	4.40	4.18	3.98	0.00	0.00
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.10%	0.04%	0.01%	0.00%	0.00%
Common Equity to Total Capital	99.90%	99.96%	99.99%	0.00%	0.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.35	0.00	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.10%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.37	0.38	0.46	0.00	0.00
Quick Ratio	0.08	0.13	0.19	0.00	0.00
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-240	-176	-122	0.00	0.00
Operating Cash Flow to CapEx	3,870.40%	11,873.66%	0.00%	8,105.69%	0.00%
Free Cash Flow to Firm to Interest Expense	-972.55	-697.22	-543.09	0.00	0.00
Operating Cash Flow to Interest Expense	193.21	474.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	188.21	470.01	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.26	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	59.62	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	260	196	134	0.00	0.00
Invested Capital Turnover	3.52	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	260	196	134	0.00	0.00
Enterprise Value (EV)	1,187	736	-27	0.00	0.00
Market Capitalization	1,328	915	191	128	128
Book Value per Share	$11.97	$11.17	$12.29	$0.00	$0.00
Tangible Book Value per Share	$11.97	$11.17	$12.29	$0.00	$0.00
Total Capital	391	365	340	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	-141	-179	-218	0.00	0.00
Capital Expenditures (CapEx)	1.23	1.01	0.00	1.09	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-994	-904	-774	0.00	0.00
Debt-free Net Working Capital (DFNWC)	-852	-725	-556	0.00	0.00
Net Working Capital (NWC)	-852	-725	-556	0.00	0.00
Net Nonoperating Expense (NNE)	8.59	8.20	7.18	4.37	3.85
Net Nonoperating Obligations (NNO)	-131	-169	-206	0.00	0.00
Total Depreciation and Amortization (D&A)	0.04	0.19	0.00	0.02	0.00
Debt-free, Cash-free Net Working Capital to Revenue	-217.08%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	-186.25%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	-186.25%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.35	$0.37	$0.20	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	32.66M	32.66M	27.65M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.34	$0.36	$0.20	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	33.71M	33.26M	27.77M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.66M	32.66M	32.66M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	20	20	13	13	10
Normalized NOPAT Margin	16.31%	17.38%	12.85%	17.19%	15.90%
Pre Tax Income Margin	11.79%	13.55%	7.49%	14.80%	12.93%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	59.58	63.78	34.08	0.00	0.00
NOPAT to Interest Expense	81.04	80.53	56.75	0.00	0.00
EBIT Less CapEx to Interest Expense	54.59	59.79	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	76.05	76.54	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Bowhead Specialty's Financials

When does Bowhead Specialty's fiscal year end?

According to the most recent income statement we have on file, Bowhead Specialty's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Bowhead Specialty's net income changed over the last 2 years?

Bowhead Specialty's net income appears to be on an upward trend, with a most recent value of $38.24 million in 2024, rising from $11.26 million in 2022. The previous period was $25.05 million in 2023. See Bowhead Specialty's forecast for analyst expectations on what’s next for the company.

What is Bowhead Specialty's operating income?

Bowhead Specialty's total operating income in 2024 was $88.45 million, based on the following breakdown:

Total Gross Profit: $177.56 million
Total Operating Expenses: $89.11 million

How has Bowhead Specialty revenue changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's total revenue changed from $187.60 million in 2022 to $425.66 million in 2024, a change of 126.9%.

How much debt does Bowhead Specialty have?

Bowhead Specialty's total liabilities were at $1.28 billion at the end of 2024, a 53.6% increase from 2023, and a 53.6% increase since 2023.

How much cash does Bowhead Specialty have?

In the past 1 years, Bowhead Specialty's cash and equivalents has ranged from $97.48 million in 2024 to $118.07 million in 2023, and is currently $97.48 million as of their latest financial filing in 2024.

How has Bowhead Specialty's book value per share changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's book value per share changed from 0.00 in 2022 to 11.33 in 2024, a change of 1,133.5%.

Related Companies

This page (NYSE:BOW) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bowhead Specialty (BOW) Financials

Frequently Asked Questions About Bowhead Specialty's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bowhead Specialty (BOW) Financials

Annual Income Statements for Bowhead Specialty

Quarterly Income Statements for Bowhead Specialty

Annual Cash Flow Statements for Bowhead Specialty

Quarterly Cash Flow Statements for Bowhead Specialty

Annual Balance Sheets for Bowhead Specialty

Quarterly Balance Sheets for Bowhead Specialty

Annual Metrics And Ratios for Bowhead Specialty

Quarterly Metrics And Ratios for Bowhead Specialty

Frequently Asked Questions About Bowhead Specialty's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools